Very low density lipoprotein receptor subtype II silencing by RNA interference inhibits cell proliferation in hepatoma cell lines.
Luo
Min
M
Institute of Liver Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China.
Liu
Yong-Jian
YJ
Xia
Li-Min
LM
Yan
Wei
W
Zhu
Qian
Q
Tian
De-An
DA
D006528:Carcinoma, Hepatocellular / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D019938:Cyclin D1 / Q000378:metabolism; D056945:Hep G2 Cells; D006801:Humans; D008079:Lipoproteins, VLDL / Q000235:genetics* / Q000378:metabolism; D008113:Liver Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D010105:Oxygenases; D034622:RNA Interference; D012333:RNA, Messenger / Q000378:metabolism; D011973:Receptors, LDL / Q000235:genetics* / Q000378:metabolism
D008079:Lipoproteins, VLDL; D012333:RNA, Messenger; D011973:Receptors, LDL; C540760:very low density lipoprotein receptor type II, human; D019938:Cyclin D1; D010105:Oxygenases; C021555:methane monooxygenase